ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AstraZeneca Recovers Global Rights to brazikumab from Allergan
May 14, 2020AstraZeneca has completed a previously communicated agreement to recover the global rights to brazikumab (formerly MEDI2070), a monoclonal antibody targeting IL23, from Allergan. -
AstraZeneca regains global rights to brazikumab from Allergan
May 12, 2020AstraZeneca has regained global rights to brazikumab (previously MEDI2070) from Allergan, following the termination of a prior licensing deal between the companies.
Pharma Sources Insight January 2025
